Table 4.
AKI and death risk in COVID-19: patient characteristics.
| Authors | Male, n | Age, Years | CKD |
|---|---|---|---|
| YANG Xiaobo et al. | 35 (67%) | 59.7 ± 13.3 | NA |
| LU Zhibing et al. | 61 (49.5%) | 57.8 ± 12.7 | 7 (5.7%) |
| ZHOU Fei et al. | 119 (62%) | 56 (46–67) | 2 (1.0%) |
| DENG Yan et al. | 124 (55.1%) | 54 (33–74) | NA |
| CHENG Yichun et al. | 367 (52.4%) | 63 (50–71) | 14 (2.0%) |
| LUO Xiaomin et al. | 193 (47.9%) | 56 (39–68) | 7 (1.7%) |
| CAO Wen et al. | 36 (59%) | 61 (48–70) | NA |
| XU Shen et al. | NA | NA | NA |
| CHEN Tao et al. | 171 (62.4%) | 62 (44–70) | 4 (1.4%) |
| WANG Lang et al. | 166 (48.9%) | 69 (65–76) | 13 (3.8%) |
| RICHARDSON Safiya et al. | 3437 (60.3%) | 63 (52–75) | 268 (4.7%) |
| PEI Guangchang et al. | 182 (54.7%) | 56.3 ± 13.4 | NA |
| CHAN Lili et al. | 1868 (52.8%) | 66.5 (55–78) | 323 (10%) |
| WANG Dawei and Yin D. et al. | 57 (53.3%) | 51 (36–65) | 3 (2.8%) |
| SHI Qiao et al. | 150 (49%) | 64.5 (56–72) | 12 (3.9%) |
| HIRSCH Jamie et al. | 3317 (60.9%) | 64 (52–75) | NA |
| YANG Kunyu et al. | 96 (47%) | 63 (56–70) | 4 (1.9%) |
| LIM, Jeong-Hoon et al. | 86 (53%) | 68.5 (24–98) | NA |
| ZHAO Mengmeng et al. | 466 (46.6%) | 61 (46, 70) | 24 (2.4%) |
| PELAYO Jerald et al. | 108 (48.4%) | 65.9 | 39 (17.8%) |